Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Neurobiology of Aging
|
December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
Bazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Clinical Epigenetics
|
February 9, 2016
Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome
Sarah Brasa, Arne Mueller, Sébastien Jacquemont, et al.
Neuroimage
|
February 5, 2021
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [<sup>11</sup>C]-ABP688 PET imaging in healthy volunteers
Johannes Streffer, Valerie Treyer, Alfred Buck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 18, 2015
A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease
Ralf Reilmann, Marie-Laure Rouzade-Dominguez, Carsten Saft, et al.
Bioorganic & Medicinal Chemistry
|
March 14, 2007
Synthesis and preliminary pharmacological evaluation of the four stereoisomers of (2S)-2-(2'-phosphono-3'-phenylcyclopropyl)glycine, the first class of 3'-substituted trans C1'-2'-2-(2'-phosphonocyclopropyl)glycines
Maura Marinozzi, Michaela Serpi, Laura Amori, et al.
Journal of Neuroinflammation
|
February 9, 2023
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
Nicolau Beckmann, Anna Neuhaus, Stefan Zurbruegg, et al.
Human Molecular Genetics
|
March 29, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
Sébastien Jacquemont, Laura Pacini, Aia E Jønch, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
October 11, 2017
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study
Chadi G Abdallah, Jonas Hannestad, Graeme F Mason, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 16, 2016
In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [<sup>11</sup>C]ABP688 and [<sup>18</sup>F]FPEB
Christine DeLorenzo, Jean-Dominique Gallezot, John Gardus, et al.
Neurobiology of Disease
|
February 15, 2011
AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
Josien Levenga, Shigemi Hayashi, Femke M S de Vrij, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Neurobiology of Aging
|
December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
Bazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Clinical Epigenetics
|
February 9, 2016
Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome
Sarah Brasa, Arne Mueller, Sébastien Jacquemont, et al.
Neuroimage
|
February 5, 2021
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [<sup>11</sup>C]-ABP688 PET imaging in healthy volunteers
Johannes Streffer, Valerie Treyer, Alfred Buck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 18, 2015
A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease
Ralf Reilmann, Marie-Laure Rouzade-Dominguez, Carsten Saft, et al.
Bioorganic & Medicinal Chemistry
|
March 14, 2007
Synthesis and preliminary pharmacological evaluation of the four stereoisomers of (2S)-2-(2'-phosphono-3'-phenylcyclopropyl)glycine, the first class of 3'-substituted trans C1'-2'-2-(2'-phosphonocyclopropyl)glycines
Maura Marinozzi, Michaela Serpi, Laura Amori, et al.
Journal of Neuroinflammation
|
February 9, 2023
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
Nicolau Beckmann, Anna Neuhaus, Stefan Zurbruegg, et al.
Human Molecular Genetics
|
March 29, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
Sébastien Jacquemont, Laura Pacini, Aia E Jønch, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
October 11, 2017
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study
Chadi G Abdallah, Jonas Hannestad, Graeme F Mason, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 16, 2016
In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [<sup>11</sup>C]ABP688 and [<sup>18</sup>F]FPEB
Christine DeLorenzo, Jean-Dominique Gallezot, John Gardus, et al.
Neurobiology of Disease
|
February 15, 2011
AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
Josien Levenga, Shigemi Hayashi, Femke M S de Vrij, et al.
Page
of 7